Hardly any retrace possible with
1) the current uncertainty about FDA investigation
2) general sell decline of the testosterone market
3) Axiron not improving market share.
Any retrace would only happen when 1) has been removed and therefore 2) & 3) will improve.
If 2) continue to deteriorate then I doubt Ell Lily will put more time, money and effort in marketing the product to try improve the market share.
Hardly any retrace possible with 1) the current uncertainty...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.31M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31248 | 6.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.3¢ | 230127 | 1 |
View Market Depth
| Last trade - 07.02am 08/07/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable